Canary Wharf Group (“CWG”) and Dutch company Kadans Science Partner (“Kadans”) have formed a joint venture to develop a new 750,000 sq ft GIA life-science focused, wet lab enabled building at Canary Wharf in London. The development will be the first phase in the creation of a world leading centre for health and life sciences on the 3.3-hectare North Quay site next to the new Elizabeth line station.
The project brings together two market leaders with highly complementary skills and resources. CWG’s construction, development and placemaking experience is complimented by Kadans’ expertise as a European leader in the development and management of life sciences buildings and ecosystems.
The new 750,000 sq ft building with space across 22 storeys, should be delivered in 2026 and will be the largest commercial wet lab enabled life science building in Europe. Most Importantly it will be a purpose-built laboratory building, with full flexibility allowing lab space on all floors.
Designed by KPF and developed to the highest sustainability and technological standards, the building will leverage Kadans’ experience of curating multi-let lab and office projects within energetic and vibrant communities. The building will create a commercial lab space under one roof, housing SME’s (it is also anticipated to include many start-ups and/or spin-offs) and academics as well as global healthcare and pharmaceutical companies.
Canary Wharf is best known as London’s foremost financial district, with some of the world’s largest international banks and financial institutions (and home to many renown Fintech start-up companies of which many are located in one of Europe’s largest tech accelerator, Level 39), will also become an enormous new scheme that will be a critical international hub for life sciences companies.
Canary Wharf Group 30th March 2022